Linked Life Data

6803556

Source:http://linkedlifedata.com/resource/pubmed/id/6803556

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1982-6-24
pubmed:abstractText
The effect of pindolol, a new beta-blocking agent, was evaluated in 12 patients with proven coronary disease (CAD) and angina pectoris. Evaluation was done using a double-blind crossover technique comparing pindolol at both 15 mg/day and 30 mg/day to placebo. Compared with placebo, pindolol slightly decreased the number of anginal episodes and nitroglycerin pills consumed while showing evidence of beta blockade during exercise. However, we could not demonstrate any effect on exercise endurance on the treadmill at either dose. Pindolol shows a modest beneficial effect on ischemic manifestations in CAD patients with angina pectoris.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0002-8703
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
830-3
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study